Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Avanos Medical Expects FY23 Revenue Between $675M-$685M Vs. 680.63M Estimate, Expects FY23 Adjusted EPS Of $1.05-$1.15 Vs. 1.09 Estimate (Prior Outlook: $1.05-$1.15)

Author: Benzinga Newsdesk | November 01, 2023 07:21am

Posted In: AVNS